NUE
54
3
CVS
52
-4
MLM
43
2
RCL
72
-4
ETR
65
2
FLR
59
-3
JPM
60
-2
CMCSA
50
-2
PEG
60
2
SYK
44
-2
MU
35
-7
BRK.B
45
-4
APD
52
-7
ROST
50
-2
DAL
62
-2
TMO
58
-2
INTC
39
-4
VLO
32
6
ADBE
49
-3
EIX
72
2
NUE
54
3
CVS
52
-4
MLM
43
2
RCL
72
-4
ETR
65
2
FLR
59
-3
JPM
60
-2
CMCSA
50
-2
PEG
60
2
SYK
44
-2
MU
35
-7
BRK.B
45
-4
APD
52
-7
ROST
50
-2
DAL
62
-2
TMO
58
-2
INTC
39
-4
VLO
32
6
ADBE
49
-3
EIX
72
2
Financhill
Back

Adverum Biotechnologies Vs. Editas Medicine Industry Stock Comparison

Sell
32

ADVM
Adverum Biotechnologies

Last Price:
6.85
Seasonality Move:
-1.86%
Sell
34

EDIT
Editas Medicine

Last Price:
3.21
Seasonality Move:
20.06%
Sell
32
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.59. The Score for ADVM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.28. The Score for EDIT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.65 Sell
Chaikin Money Flow: -165680 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.74 - 7.22) Sell
Bollinger Bands (100): (6.72 - 8.12) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 32.94 Sell
Chaikin Money Flow: -745563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.47 - 3.83) Sell
Bollinger Bands (100): (3.88 - 5.52) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.88 Sell
20-day SMA: 6.99 Sell
50-day SMA: 7.07 Sell
200-day SMA: 10.35 Sell
8-day EMA: 6.86 Sell
20-day EMA: 6.96 Sell
50-day EMA: 7.19 Sell
200-day EMA: 9.37 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.5 Sell
20-day SMA: 3.64 Sell
50-day SMA: 4.1 Sell
200-day SMA: 6.3 Sell
8-day EMA: 3.49 Sell
20-day EMA: 3.65 Sell
50-day EMA: 4.05 Sell
200-day EMA: 5.84 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.62 per share, and an increase next year of $0.42 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):